Bosh sahifaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Yopilish kursi
714,30 ₹
Kunlik diapazon
715,15 ₹ - 749,10 ₹
Yillik diapazon
603,80 ₹ - 1 997,40 ₹
Bozor kapitalizatsiyasi
37,51 mlrd INR
Oʻrtacha hajm
197,26 ming
Narx/foyda
37,63
Dividend daromadliligi
-
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,37 mlrd | 9,39% |
Joriy xarajat | 803,51 mln | 65,13% |
Sof foyda | 222,95 mln | -33,50% |
Sof foyda marjasi | 9,39 | -39,18% |
Har bir ulushga tushum | 4,40 | — |
EBITDA | 277,48 mln | -6,06% |
Amaldagi soliq stavkasi | -0,18% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,80 mlrd | 4 868,40% |
Jami aktivlari | 16,88 mlrd | 8,63% |
Jami passivlari | 4,21 mlrd | 9,42% |
Umumiy kapital | 12,67 mlrd | — |
Tarqatilgan aksiyalar | 50,67 mln | — |
Narxi/balansdagi bahosi | 2,86 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 3,38% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 222,95 mln | -33,50% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Tashkil etilgan
1992
Sayt
Xodimlar soni
871
